Page last updated: 2024-10-26

etodolac and Experimental Mammary Neoplasms

etodolac has been researched along with Experimental Mammary Neoplasms in 2 studies

Etodolac: A non-steroidal anti-inflammatory agent and cyclooxygenase-2 (COX-2) inhibitor with potent analgesic and anti-arthritic properties. It has been shown to be effective in the treatment of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; and in the alleviation of postoperative pain (PAIN, POSTOPERATIVE).
etodolac : A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl moiety. A preferential inhibitor of cyclo-oxygenase 2 and non-steroidal anti-inflammatory, it is used for the treatment of rheumatoid arthritis and osteoarthritis, and for the alleviation of postoperative pain. Administered as the racemate, only the (S)-enantiomer is active.

Research Excerpts

ExcerptRelevanceReference
"Celecoxib (100 µM) was found to induce downregulation of COX-2 protein expression."1.40Usefulness of selective COX-2 inhibitors as therapeutic agents against canine mammary tumors. ( Asano, R; Saito, T; Tamura, D, 2014)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Saito, T1
Tamura, D1
Asano, R1
Sugihara, I1
Yoshida, M1
Shigenobu, T1
Takagi, H1
Maruyama, K1
Takeuchi, N1
Toda, M1
Inoue, M1
Nakada, H1

Other Studies

2 other studies available for etodolac and Experimental Mammary Neoplasms

ArticleYear
Usefulness of selective COX-2 inhibitors as therapeutic agents against canine mammary tumors.
    Oncology reports, 2014, Volume: 31, Issue:4

    Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Celecoxib; Cell Line, Tumor; Cell Prol

2014
Different progression of tumor xenografts between mucin-producing and mucin-non-producing mammary adenocarcinoma-bearing mice.
    Cancer research, 2006, Jun-15, Volume: 66, Issue:12

    Topics: Adenocarcinoma; Animals; Cell Growth Processes; Cell Line, Tumor; Cyclooxygenase 2; Cyclooxygenase 2

2006